Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.
Mahlangu J, Kaczmarek R, von Drygalski A, Shapiro S, Chou SC, Ozelo MC, Kenet G, Peyvandi F, Wang M, Madan B, Key NS, Laffan M, Dunn AL, Mason J, Quon DV, Symington E, Leavitt AD, Oldenburg J, Chambost H, Reding MT, Jayaram K, Yu H, Mahajan R, Chavele KM, Reddy DB, Henshaw J, Robinson TM, Wong WY, Pipe SW; GENEr8-1 Trial Group. Mahlangu J, et al. Among authors: key ns. N Engl J Med. 2023 Feb 23;388(8):694-705. doi: 10.1056/NEJMoa2211075. N Engl J Med. 2023. PMID: 36812433 Clinical Trial.
Fewer severe infections with tranexamic acid in patients with hematologic malignancies.
Poston JN, Brown SP, Ilich A, Ginsburg AS, Herren H, El Kassar N, Jensen CE, Triulzi DJ, Key NS, May S, Gernsheimer TB. Poston JN, et al. Among authors: key ns. Res Pract Thromb Haemost. 2024 Mar 1;8(2):102358. doi: 10.1016/j.rpth.2024.102358. eCollection 2024 Feb. Res Pract Thromb Haemost. 2024. PMID: 38666065 Free PMC article.
Plasma kallikrein supports FXII-independent thrombin generation in mouse whole blood.
Wan J, Dhrolia S, Kasthuri RR, Prokopenko Y, Ilich A, Saha P, Roest M, Wolberg AS, Key NS, Pawlinski R, Bendapudi PK, Mackman N, Grover SP. Wan J, et al. Among authors: key ns. Blood Adv. 2024 Apr 9:bloodadvances.2024012613. doi: 10.1182/bloodadvances.2024012613. Online ahead of print. Blood Adv. 2024. PMID: 38593231
Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia.
Hisada Y, Archibald SJ, Bansal K, Chen Y, Dai C, Dwarampudi S, Balas N, Hageman L, Key NS, Bhatia S, Bhatia R, Mackman N, Gangaraju R. Hisada Y, et al. Among authors: key ns. J Thromb Haemost. 2024 Apr 2:S1538-7836(24)00178-8. doi: 10.1016/j.jtha.2024.03.020. Online ahead of print. J Thromb Haemost. 2024. PMID: 38574862
Emicizumab promotes factor Xa generation on endothelial cells.
Fager AM, Ellsworth P, Key NS, Monroe DM, Hoffman M. Fager AM, et al. Among authors: key ns. J Thromb Haemost. 2024 Mar 8:S1538-7836(24)00121-1. doi: 10.1016/j.jtha.2024.02.017. Online ahead of print. J Thromb Haemost. 2024. PMID: 38460838
Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial.
Coppens M, Pipe SW, Miesbach W, Astermark J, Recht M, van der Valk P, Ewenstein B, Pinachyan K, Galante N, Le Quellec S, Monahan PE, Leebeek FWG; HOPE-B Investigators. Coppens M, et al. Lancet Haematol. 2024 Apr;11(4):e265-e275. doi: 10.1016/S2352-3026(24)00006-1. Epub 2024 Mar 1. Lancet Haematol. 2024. PMID: 38437857 Clinical Trial.
Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia.
Hisada Y, Archibald SJ, Bansal K, Chen Y, Dai C, Dwarampudi S, Balas N, Hageman L, Key NS, Bhatia S, Bhatia R, Mackman N, Gangaraju R. Hisada Y, et al. Among authors: key ns. medRxiv [Preprint]. 2023 Oct 19:2023.10.18.23297216. doi: 10.1101/2023.10.18.23297216. medRxiv. 2023. PMID: 37905148 Free PMC article. Updated. Preprint.
318 results